Understanding Patient Engagement Trends in TBI Clinical Research

Power Life Sciences

Status: Not yet enrolling

Conditions: TBI

Study type: Observational

Funder types: Industry

Identifiers

NCT06288698

53955721

Details and patient eligibility

About

Clinical trials, specifically focused on TBI, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation.

The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Ability to understand and the willingness to sign a written informed consent document
• Participant must be 18 years of age or older
• Confirmed diagnosis of TBI

Exclusion criteria

• Enrolled in another research study
• Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study
• Inability to provide written informed consent

Trial design